These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

696 related items for PubMed ID: 16609023

  • 1. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S, Shiina H, Enokida H, Kawakami T, Kawamoto K, Hirata H, Tanaka Y, Kikuno N, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [Abstract] [Full Text] [Related]

  • 2. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S, Shiina H, Enokida H, Hirata H, Kawamoto K, Kawakami T, Kikuno N, Tanaka Y, Majid S, Nakagawa M, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Dec 01; 12(23):6989-97. PubMed ID: 17145819
    [Abstract] [Full Text] [Related]

  • 3. Multigene methylation analysis for detection and staging of prostate cancer.
    Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R.
    Clin Cancer Res; 2005 Sep 15; 11(18):6582-8. PubMed ID: 16166436
    [Abstract] [Full Text] [Related]

  • 4. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.
    Clin Cancer Res; 2006 Jan 15; 12(2):383-91. PubMed ID: 16428476
    [Abstract] [Full Text] [Related]

  • 5. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO, Begum S, Topaloglu O, Chatterjee A, Rosenbaum E, Van Criekinge W, Westra WH, Schoenberg M, Zahurak M, Goodman SN, Sidransky D.
    J Natl Cancer Inst; 2006 Jul 19; 98(14):996-1004. PubMed ID: 16849682
    [Abstract] [Full Text] [Related]

  • 6. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients.
    Friedrich MG, Weisenberger DJ, Cheng JC, Chandrasoma S, Siegmund KD, Gonzalgo ML, Toma MI, Huland H, Yoo C, Tsai YC, Nichols PW, Bochner BH, Jones PA, Liang G.
    Clin Cancer Res; 2004 Nov 15; 10(22):7457-65. PubMed ID: 15569975
    [Abstract] [Full Text] [Related]

  • 7. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB, Lee EJ, Jung EH, Chun HK, Chang DK, Song SY, Park J, Kim DH.
    Clin Cancer Res; 2009 Oct 01; 15(19):6185-91. PubMed ID: 19773381
    [Abstract] [Full Text] [Related]

  • 8. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.
    Oncogene; 2005 Nov 24; 24(53):7946-52. PubMed ID: 16007117
    [Abstract] [Full Text] [Related]

  • 9. WNT pathway in oral cancer: epigenetic inactivation of WNT-inhibitors.
    Pannone G, Bufo P, Santoro A, Franco R, Aquino G, Longo F, Botti G, Serpico R, Cafarelli B, Abbruzzese A, Caraglia M, Papagerakis S, Lo Muzio L.
    Oncol Rep; 2010 Oct 24; 24(4):1035-41. PubMed ID: 20811686
    [Abstract] [Full Text] [Related]

  • 10. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
    Chan MW, Chan LW, Tang NL, Tong JH, Lo KW, Lee TL, Cheung HY, Wong WS, Chan PS, Lai FM, To KF.
    Clin Cancer Res; 2002 Feb 24; 8(2):464-70. PubMed ID: 11839665
    [Abstract] [Full Text] [Related]

  • 11. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer.
    Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J.
    Clin Cancer Res; 2007 Dec 15; 13(24):7296-304. PubMed ID: 18094410
    [Abstract] [Full Text] [Related]

  • 12. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
    Guo B, Luo C, Xun C, Xie J, Wu X, Pu J.
    Exp Oncol; 2009 Mar 15; 31(1):43-7. PubMed ID: 19300416
    [Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S, Swellam M, Sadek M, Mourad MS, El Ahmady O, Khalifa A.
    J Urol; 2002 Aug 15; 168(2):465-9. PubMed ID: 12131289
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T, Suzuki H, Nojima M, Kitamura H, Yamamoto E, Maruyama R, Ashida M, Hatahira T, Kai M, Masumori N, Tokino T, Imai K, Tsukamoto T, Toyota M.
    Eur Urol; 2013 Jun 15; 63(6):1091-100. PubMed ID: 23200812
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identification of novel epigenetic markers for clear cell renal cell carcinoma.
    Dalgin GS, Drever M, Williams T, King T, DeLisi C, Liou LS.
    J Urol; 2008 Sep 15; 180(3):1126-30. PubMed ID: 18639284
    [Abstract] [Full Text] [Related]

  • 20. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul 15; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.